Stock listing
OTC:EMMA Emmaus Life Sciences, Inc. Stock
Follow Emmaus Life Sciences, Inc. into a list and get an email when it puts out news.
Share price · OTC:EMMA
$0.022 USD +0.001 (+4.3%)
Close on Nov 11, 2026
- Day range
- $0.012 – $0.022 USDNov 11, 2026
- Volume
- 19,000 sharesNov 11, 2026
- Market cap
- $1.54M USDAt the close on Nov 11, 2026 · price × 70.19M shares outstanding
- 52-week range
- $0.0080 – $0.088 USDLowest and highest trades, Nov 12, 2025 – Nov 11, 2026
- Traded on an average day
- $4,431 USDMedian day 19,864 shares · 14 days with no trades · last 3 months, Aug 11, 2026 – Nov 11, 2026

Daily closes
Last 3 months, Aug 11, 2026 – Nov 11, 2026 · OTC:EMMA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.022 | +0.001 | +4.3% | $0.012 | $0.022 | $0.012 | 19,000 | |
| $0.021 | -0.004 | -16.0% | $0.025 | $0.025 | $0.021 | 18,369 | |
| $0.025 | 0.000 | 0.0% | $0.025 | $0.025 | $0.025 | 18,890 | |
| $0.025 | 0.000 | 0.0% | $0.025 | $0.025 | $0.025 | 0 | |
| $0.025 | -0.002 | -8.8% | $0.032 | $0.033 | $0.025 | 50,000 | |
| $0.027 | -0.013 | -31.5% | $0.036 | $0.036 | $0.023 | 82,000 | |
| $0.040 | +0.005 | +13.6% | $0.040 | $0.040 | $0.040 | 10,000 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | -0.005 | -13.5% | $0.031 | $0.035 | $0.030 | 38,036 | |
| $0.041 | +0.001 | +1.7% | $0.036 | $0.041 | $0.036 | 7,202 | |
| $0.040 | -0.006 | -13.0% | $0.046 | $0.046 | $0.040 | 41,722 | |
| $0.046 | -0.012 | -20.1% | $0.046 | $0.046 | $0.046 | 15,500 | |
| $0.058 | 0.000 | 0.0% | $0.058 | $0.058 | $0.058 | 0 | |
| $0.058 | -0.006 | -10.0% | $0.058 | $0.058 | $0.058 | 301 | |
| $0.064 | 0.000 | 0.0% | $0.064 | $0.064 | $0.064 | 0 | |
| $0.064 | +0.014 | +28.0% | $0.046 | $0.065 | $0.046 | 20,385 | |
| $0.050 | -0.008 | -14.4% | $0.043 | $0.056 | $0.042 | 19,620 | |
| $0.058 | 0.000 | 0.0% | $0.042 | $0.065 | $0.042 | 37,235 | |
| $0.058 | 0.000 | 0.0% | $0.058 | $0.058 | $0.058 | 0 | |
| $0.058 | -0.002 | -2.7% | $0.058 | $0.058 | $0.058 | 350 | |
| $0.060 | +0.017 | +40.2% | $0.050 | $0.060 | $0.050 | 47,000 | |
| $0.043 | 0.000 | 0.0% | $0.043 | $0.043 | $0.043 | 0 | |
| $0.043 | -0.018 | -29.0% | $0.050 | $0.050 | $0.043 | 26,055 | |
| $0.060 | +0.000 | +0.2% | $0.063 | $0.063 | $0.060 | 10,800 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | 0.000 | 0.0% | $0.060 | $0.060 | $0.060 | 0 | |
| $0.060 | +0.018 | +42.7% | $0.060 | $0.060 | $0.060 | 2,025 | |
| $0.042 | -0.023 | -35.1% | $0.059 | $0.059 | $0.042 | 20,250 | |
| $0.065 | -0.001 | -0.8% | $0.065 | $0.065 | $0.059 | 3,295 | |
| $0.066 | 0.000 | 0.0% | $0.066 | $0.066 | $0.066 | 0 | |
| $0.066 | 0.000 | 0.0% | $0.066 | $0.066 | $0.066 | 0 | |
| $0.066 | -0.002 | -3.4% | $0.063 | $0.066 | $0.063 | 8,435 | |
| $0.068 | +0.006 | +9.9% | $0.068 | $0.068 | $0.062 | 14,105 | |
| $0.062 | 0.000 | 0.0% | $0.062 | $0.062 | $0.062 | 0 | |
| $0.062 | -0.003 | -5.1% | $0.063 | $0.068 | $0.062 | 6,200 | |
| $0.065 | +0.001 | +1.6% | $0.068 | $0.068 | $0.065 | 59,675 | |
| $0.064 | -0.004 | -5.7% | $0.064 | $0.064 | $0.064 | 9,920 | |
| $0.068 | +0.013 | +22.8% | $0.065 | $0.068 | $0.065 | 110,891 | |
| $0.055 | -0.006 | -10.4% | $0.060 | $0.065 | $0.040 | 345,498 | |
| $0.062 | +0.000 | +0.3% | $0.068 | $0.068 | $0.056 | 20,108 | |
| $0.062 | -0.007 | -9.8% | $0.063 | $0.064 | $0.062 | 20,970 | |
| $0.068 | +0.017 | +32.2% | $0.068 | $0.068 | $0.068 | 10,000 | |
| $0.052 | 0.000 | 0.0% | $0.052 | $0.052 | $0.052 | 0 | |
| $0.052 | 0.000 | 0.0% | $0.052 | $0.052 | $0.052 | 0 | |
| $0.052 | -0.013 | -19.5% | $0.064 | $0.065 | $0.052 | 38,888 | |
| $0.064 | +0.004 | +6.5% | $0.065 | $0.065 | $0.064 | 6,224 | |
| $0.060 | -0.001 | -1.6% | $0.061 | $0.068 | $0.060 | 41,376 | |
| $0.061 | -0.010 | -13.8% | $0.080 | $0.080 | $0.061 | 44,725 | |
| $0.071 | +0.006 | +9.2% | $0.070 | $0.080 | $0.068 | 87,358 | |
| $0.065 | +0.005 | +8.5% | $0.060 | $0.072 | $0.054 | 155,520 | |
| $0.060 | -0.023 | -27.8% | $0.088 | $0.088 | $0.037 | 1,072,236 | |
| $0.083 | +0.032 | +62.7% | $0.055 | $0.083 | $0.047 | 396,664 | |
| $0.051 | +0.009 | +21.7% | $0.042 | $0.051 | $0.041 | 92,806 | |
| $0.042 | +0.003 | +7.4% | $0.039 | $0.043 | $0.036 | 106,045 | |
| $0.039 | -0.002 | -4.9% | $0.037 | $0.039 | $0.031 | 110,822 | |
| $0.041 | +0.009 | +27.7% | $0.032 | $0.044 | $0.032 | 373,755 | |
| $0.032 | +0.006 | +23.0% | $0.028 | $0.032 | $0.017 | 847,102 | |
| $0.026 | +0.013 | +102.3% | $0.015 | $0.038 | $0.015 | 1,506,647 | |
| $0.013 | +0.002 | +17.3% | $0.011 | $0.013 | $0.011 | 52,020 | |
| $0.011 | -0.001 | -4.3% | $0.012 | $0.013 | $0.011 | 1,089,555 | |
| $0.012 | 0.000 | 0.0% | $0.013 | $0.013 | $0.012 | 323,200 | |
| $0.012 | 0.000 | 0.0% | $0.012 | $0.012 | $0.012 | 120,008 | |
| $0.012 | -0.001 | -8.0% | $0.012 | $0.012 | $0.011 | 100,000 | |
| $0.013 | +0.001 | +8.7% | $0.013 | $0.013 | $0.013 | 100 | |
| $0.012 | 0.000 | 0.0% | $0.014 | $0.014 | $0.012 | 121,000 |
Splits
3 splits since 2012 · OTC:EMMA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-6 | Consolidation | |
| 1-for-200 | Consolidation | |
| 1-for-30 | Consolidation |
- Ticker
- OTC:EMMA
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Emmaus Life Sciences Reports Quarterly Financial Results
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 27 slides
Latest news
Emmaus Life Sciences, Inc. on 6ix
- News releases
- 2 in the last 12 months · 2 in all · newest Nov 19, 2026 · oldest 2026
- Decks
- 15 decks · latest August 2026
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 11, 2026
- Enterprise value
- $25.59M USD
- P/E
- Loss
- EV/sales
- 1.8×
- EV/EBITDA
- 7.2×
- Price/book
- Negative equity
- Gross margin
- 92.0%
- Operating margin
- 24.8%
- Net margin
- −61.9%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- -0.14
Team and board
Officers
| Officer | Role |
|---|---|
| Willis C. Lee | Chief Executive Officer, Chairman of the Board |
| Dale E. Short | Legal Consultant and Corporate Secretary |
| Charles W. Stark | Senior Vice President of Medical Affairs, Clinical, Regulatory |
| Hiroko Huynh | Chief Accounting Officer |
Board
| Director | Role |
|---|---|
| Willis C. Lee | Chief Executive Officer, Chairman of the Board |
| Henry Du | Director |
| Wei Peu Zen | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Nov 20, 2025 | −5.0% |
| Q2 2025 | Sep 8, 2025 · Before open | −7.6% |
| Q1 2025 | Apr 14, 2025 | +3.2% |
| Q3 2024 | Nov 12, 2024 · Before open | 0.0% |
| Q2 2024 | Jul 3, 2024 · Before open | +1.3% |
| Q1 2024 | Apr 30, 2024 · Before open | 0.0% |
| Q4 2023 | Mar 29, 2024 | +8.4% |
| Q3 2023 | Nov 14, 2023 · Before open | 0.0% |
| Q2 2023 | Aug 14, 2023 · After close | 0.0% |
| Q1 2023 | May 15, 2023 · Before open | 0.0% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Mar 31, 2023 · After close | −0.2% |
| Q3 2022 | Nov 14, 2022 · After close | −20.0% |
| Q2 2022 | Aug 15, 2022 · After close | 0.0% |
| Q1 2022 | May 13, 2022 · Before open | −21.5% |
| Q4 2021 | Mar 31, 2022 · After close | 0.0% |
| Quarter to Sep 30, 2021 | Nov 12, 2021 · After close | +0.8% |
| Quarter to Jun 30, 2021 | Sep 2, 2021 · After close | −0.7% |
| Quarter to Mar 31, 2021 | May 4, 2021 · Before open | −4.2% |
| Quarter to Dec 31, 2020 | Jan 25, 2021 · Before open | −9.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2026) | Investor deck | 27 slides | August 2026 |
| Investor Presentation (April 2022) | Investor deck | 31 slides | April 2022 |
| Investor Presentation (November 2021) | Investor deck | 30 slides | November 2021 |
| Shareholder Meeting (October 2020) | Shareholder meeting | 18 slides | Oct 29, 2020 |
| MYnd Analytics — Investor Presentation (June 2019) | Investor deck | 25 slides | Jun 20, 2019 |
| MYnd Analytics — Merger or Acquisition (March 2019) | Merger or acquisition | 21 slides | Mar 5, 2019 |
| MYnd Analytics — JP Morgan Healthcare Conference 2019 | Conference | 21 slides | Jan 7, 2019 |
| MYnd Analytics — Investor Presentation (September 2018) | Investor deck | 27 slides | Sep 6, 2018 |
| MYnd Analytics — Investor Presentation (May 2018) | Investor deck | 25 slides | May 22, 2018 |
| MYnd Analytics — Investor Presentation (February 2018) | Investor deck | 25 slides | Feb 23, 2018 |
All 15 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| MYnd Analytics — Investor Presentation (January 2018) | Investor deck | 25 slides | Jan 5, 2018 |
| MYnd Analytics — Investor Presentation (November 2017) | Investor deck | 25 slides | Nov 28, 2017 |
| MYnd Analytics — Investor Presentation (July 2017) | Investor deck | 24 slides | Jul 28, 2017 |
| MYnd Analytics — IPO Roadshow (July 2017) | IPO roadshow | 25 slides | Jul 3, 2017 |
| MYnd Analytics — IPO Roadshow (June 2017) | IPO roadshow | 25 slides | Jun 19, 2017 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.5M | 16.7M | 29.6M | 18.4M | 20.6M | 23.2M | 22.8M | 16.5M | 1.32M | 128.5K |
| Cost of revenue | 857.0K | 1.20M | 1.34M | 2.59M | 3.31M | 2.25M | 1.09M | 993.0K | 827.4K | 53.5K |
| Gross profit | 11.6M | 15.5M | 28.3M | 15.8M | 17.3M | 20.9M | 21.7M | 15.5M | 488.1K | 75.0K |
| Research and development | 313.0K | 657.0K | 1.19M | 1.73M | 4.11M | 2.41M | 2.18M | 1.72M | ||
| Operating income | 231.0K | -1.89M | 3.54M | -6.59M | -6.13M | -32.0K | -4.51M | -8.45M | -10.2M | -7.10M |
| Depreciation and amortization | 39.0K | 22.0K | 32.0K | 53.0K | 59.0K | 60.0K | 73.0K | 61.0K | 117.9K | 48.7K |
| EBITDA | 270.0K | -1.87M | 3.57M | -6.53M | -6.07M | 28.0K | -4.44M | -8.39M | -10.1M | -7.05M |
| Interest expense | 7.13M | 5.49M | 7.38M | 5.01M | 3.10M | 5.99M | 27.6M | 22.8M | ||
| Income before tax | -7.48M | -6.42M | -3.79M | -10.6M | -15.9M | 973.0K | -54.7M | -72.5M | -10.3M | -7.11M |
| Income tax | 9.00K | 29.0K | -59.0K | 60.0K | 25.0K | -381.0K | 164.0K | 39.0K | 1.90K | 2.60K |
| Net income | -7.49M | -6.45M | -3.73M | -10.6M | -15.9M | 1.35M | -54.8M | -72.6M | -9.60M | -7.11M |
| Earnings per share, basic | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 | 30.00 | -1.30 | -1.97 | -1.86 | -2.52 |
| Earnings per share, diluted | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 | 30.00 | -1.30 | -1.97 | -1.86 | -2.52 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.13M | 1.39M | 2.55M | 2.02M | 2.28M | 2.49M | 1.77M | 3.90M | 3.25M | 5.45M |
| Short-term investments | 27.9M | 49.3M | ||||||||
| Receivables | 2.80M | 2.62M | 5.52M | 375.0K | 1.04M | 198.0K | 2.15M | 1.79M | 63.3K | 6.50K |
| Inventory | 1.55M | 1.64M | 1.71M | 2.38M | 4.39M | 7.09M | 7.97M | 4.71M | ||
| Current assets | 7.75M | 6.77M | 11.5M | 6.29M | 9.09M | 11.3M | 41.2M | 60.6M | 3.51M | 5.69M |
| Property, plant and equipment | 113.0K | 46.0K | 59.0K | 75.0K | 147.0K | 120.0K | 151.0K | 152.0K | 110.8K | 120.7K |
| Goodwill | 1.39M | 1.39M | ||||||||
| Total assets | 21.4M | 23.6M | 35.2M | 48.2M | 56.7M | 59.5M | 59.5M | 75.3M | 5.15M | 6.10M |
| Accounts payable | 5.98M | 5.17M | 5.11M | 3.79M | 2.72M | 2.02M | 7.28M | 3.47M | 346.9K | 736.9K |
| Current liabilities | 69.1M | 63.6M | 61.5M | 54.3M | 37.1M | 23.4M | 32.8M | 45.6M | 1.17M | 1.55M |
| Long-term debt | 597.1K | 587.7K | ||||||||
| Total debt | 27.1M | 29.0M | 30.6M | 30.4M | 22.3M | 15.3M | 597.1K | 587.7K | ||
| Total liabilities | 85.0M | 80.1M | 82.9M | 82.3M | 78.2M | 64.7M | 70.5M | 97.0M | 1.87M | 1.55M |
| Shareholders' equity | -63.6M | -56.5M | -47.8M | -34.1M | -21.4M | -5.16M | -11.1M | -21.7M | 4.02M | 4.55M |
| Shares outstanding | 70.2M | 63.9M | 61.8M | 49.6M | 49.3M | 49.0M | 48.5M | 37.3M | 7.41M | 4.30M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -11.0K | -2.29M | -1.50M | -5.07M | -1.25M | -2.45M | -4.52M | -5.63M | -9.04M | -4.79M |
| Capital spending | -1.00K | -12.0K | -17.0K | -26.0K | -73.0K | -15.0K | -60.0K | -94.0K | -55.2K | -127.9K |
| Free cash flow | -12.0K | -2.30M | -1.52M | -5.10M | -1.33M | -2.47M | -4.58M | -5.73M | -9.09M | -4.92M |
| Cash from investing | 2.17M | 2.50M | -432.0K | -2.39M | -6.38M | 5.47M | -1.48M | -7.44M | -361.8K | -479.5K |
| Cash from financing | -1.43M | -1.35M | 2.48M | 7.23M | 7.41M | -2.31M | 3.88M | -5.58M | 7.21M | 10.4M |
| Change in cash | 738.0K | -1.16M | 526.0K | -258.0K | -208.0K | 718.0K | -2.14M | -18.7M | -2.19M | 5.13M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 18, 2026 | Results | SEC |
| 10-Q · Quarterly report | Nov 18, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 16, 2026 | Explanation request | SEC |
| 4 · Change in ownership | Sep 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 14, 2026 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 15, 2026 | Results | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Apr 21, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 17, 2026 | Management or board change | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Apr 14, 2026 | Management or board change | SEC |
| 8-K · Current report | Mar 31, 2026 | Results | SEC |
| 10-K · Annual report | Mar 30, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 4, 2026 | Material contract | SEC |
| 8-K · Current report | Dec 30, 2025 | Material contract | SEC |
| 8-K · Current report | Dec 22, 2025 | Material contract | SEC |
| 8-K · Current report | Dec 19, 2025 | Management or board change | SEC |
| 8-K · Current report | Nov 14, 2025 | Results | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 14, 2025 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 1, 2025 | Management or board change | SEC |
| 8-K · Current report | May 15, 2025 | Results | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2025 | Current report | SEC |
| 8-K · Current report | Apr 14, 2025 | Results | SEC |
| 10-K · Annual report | Apr 14, 2025 | Annual report | SEC |
| NT 10-K · Late filing notice | Apr 1, 2025 | Explanation request | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 4, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Nov 19, 2024 | Results | SEC |
| 10-Q · Quarterly report | Nov 19, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 14, 2024 | Explanation request | SEC |
| 8-K · Current report | Nov 6, 2024 | Management or board change | SEC |
| 8-K · Current report | Oct 25, 2024 | Current report | SEC |
| 3 · Initial statement of ownership | Oct 9, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 4, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Sep 18, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 10, 2024 | Results | SEC |
| 10-Q · Quarterly report | Sep 10, 2024 | Quarterly report | SEC |
| 10-Q · Quarterly report | Sep 10, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 15, 2024 | Explanation request | SEC |
| 8-K · Current report | Jul 17, 2024 | Management or board change | SEC |
| 8-K · Current report | Jul 3, 2024 | Results | SEC |
| 10-K · Annual report | Jul 2, 2024 | Annual report | SEC |
| 8-K · Current report | May 28, 2024 | Current report | SEC |
| NT 10-K · Late filing notice | Apr 1, 2024 | Explanation request | SEC |
| 4 · Change in ownership | Feb 29, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 26, 2024 | Material contract | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 3, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Dec 22, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 21, 2023 | Insider trade | SEC |
| 3/A · Initial statement of ownership, amended | Dec 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 19, 2023 | Material contract | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 14, 2023 | Results | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Oct 4, 2023 | Management or board change | SEC |
| 8-K · Current report | Aug 23, 2023 | Management or board change | SEC |
| 8-K · Current report | Aug 14, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 8-K · Current report | May 15, 2023 | Results | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| 8-K · Current report | Mar 31, 2023 | Results | SEC |
| 10-K · Annual report | Mar 31, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 6, 2023 | Financing | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 21, 2023 | Big-stake notice | SEC |
| D | Jan 31, 2023 | Other filings | SEC |
| 4 · Change in ownership | Jan 20, 2023 | Insider trade | SEC |
| D | Jan 20, 2023 | Other filings | SEC |
| 4/A · Change in ownership, amended | Jan 19, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 19, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 9, 2022 | Meeting outcome | SEC |
| 4 · Change in ownership | Dec 1, 2022 | Insider trade | SEC |
| 8-K · Current report | Nov 14, 2022 | Results | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 9, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 31, 2022 | Insider trade | SEC |
| DEF 14A · Proxy statement | Oct 31, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Oct 24, 2022 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Oct 21, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Oct 19, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 17, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 13, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 12, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 6, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 6, 2022 | Insider trade | SEC |
| 8-K · Current report | Oct 6, 2022 | Management or board change | SEC |
| 8-K · Current report | Sep 30, 2022 | Management or board change | SEC |
| 8-K · Current report | Aug 19, 2022 | Material contract | SEC |
| 8-K · Current report | Aug 15, 2022 | Results | SEC |
| 10-Q · Quarterly report | Aug 15, 2022 | Quarterly report | SEC |
| 8-K · Current report | Aug 10, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Jul 25, 2022 | Insider trade | SEC |
| 10-K/A · Annual report, amended | Jul 1, 2022 | Annual report | SEC |
| D | Jun 30, 2022 | Other filings | SEC |
| 8-K · Current report | Jun 10, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2022 | Insider trade | SEC |
| 8-K · Current report | May 13, 2022 | Results | SEC |
| 10-Q · Quarterly report | May 12, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 12, 2022 | Insider trade | SEC |
| 8-K · Current report | Mar 31, 2022 | Results | SEC |
| 10-K · Annual report | Mar 31, 2022 | Annual report | SEC |
| 4 · Change in ownership | Mar 2, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2022 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 16, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 16, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 24, 2022 | Insider trade | SEC |
| 8-K · Current report | Jan 10, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Jan 5, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2022 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Dec 30, 2021 | Offer document | SEC |
| 3 · Initial statement of ownership | Dec 28, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 28, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 20, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 6, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2021 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Dec 1, 2021 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Nov 30, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 30, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 30, 2021 | Insider trade | SEC |
| 8-K · Current report | Nov 29, 2021 | Management or board change | SEC |
| 4 · Change in ownership | Nov 26, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 26, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2021 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2021 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 22, 2021 | Insider trade | SEC |
| DEF 14A · Proxy statement | Oct 12, 2021 | Meeting notice | SEC |
| 8-K · Current report | Oct 12, 2021 | Material contract | SEC |
| 4 · Change in ownership | Oct 7, 2021 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Sep 30, 2021 | Meeting notice | SEC |
| 4 · Change in ownership | Sep 29, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 27, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 13, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Sep 2, 2021 | Insider trade | SEC |
| 10-Q · Quarterly report | Sep 1, 2021 | Quarterly report | SEC |
| 10-Q · Quarterly report | Sep 1, 2021 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 27, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2021 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 25, 2021 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 25, 2021 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 25, 2021 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2021 | Insider trade | SEC |
| 10-K/A · Annual report, amended | Aug 9, 2021 | Annual report | SEC |
| 8-K · Current report | Aug 9, 2021 | Current report | SEC |
| 4 · Change in ownership | Aug 5, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Aug 2, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jul 22, 2021 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 20, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 15, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 28, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 14, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2021 | Insider trade | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Emmaus Life Sciences, Inc.’s releases · as of Nov 11, 2026
- Common shares
- 70,188,263
- Fully diluted
- 70,188,263
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 70,188,263 | Nov 11, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 11, 2026 | 70,188,263 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robin L. Smith Other companies: Matinas BioPharma Holdings, Inc. (Director · Feb 13, 2025 – Nov 4, 2026 · Past); Cycurion, Inc. (Director · Jan 11, 2022 – Jan 11, 2022 · Past); Celularity Inc. (Director · Jul 16, 2021 – Jun 14, 2023 · Past); ServiceSource International Inc (Director · Feb 27, 2020 – May 20, 2020 · Past); Sorrento Therapeutics, Inc. (Director · Dec 16, 2019 – Sep 3, 2021 · Past); Rockwell Medical, Inc. (Director · Jun 6, 2019 – Jun 6, 2019 · Past) | Director · May 8, 2019 – May 8, 2019 · Past |
| Andy Sassine Other companies: Arcturus Therapeutics Holdings Inc. (Chief Financial Officer, Director · Since at least Jan 1, 2019); icad inc (Director · Since at least Dec 7, 2015); Exicure, Inc. (Director · Mar 5, 2021 – Jun 2, 2021 · Past); MetaVia Inc. (Director · Aug 4, 2016 – Jul 24, 2019 · Past); Acorn Energy, Inc. (Director · Sep 20, 2013 – Sep 23, 2014 · Past) | Director · Feb 25, 2013 – Apr 5, 2016 · Past |
| Robert Dickey IV Other companies: Vyome Holdings, Inc. (Chief Financial Officer · Since at least Aug 15, 2025); Enveric Biosciences, Inc. (Chief Financial Officer · Sep 9, 2022 – Sep 9, 2022 · Past); Lisata Therapeutics, Inc. (Chief Financial Officer · Aug 19, 2013 – Dec 31, 2014 · Past); AIM ImmunoTech Inc. (Chief Financial Officer · Jun 11, 2009 – Apr 4, 2022 · Past) | Director · Jul 17, 2019 – Jul 17, 2019 · Past |
| Maurice J Dewald Other companies: Targeted Medical Pharma Inc (Director · Mar 1, 2013 – Mar 4, 2016 · Past); Healthcare Realty Trust Incorporated (Director · Apr 30, 2008 – Jul 9, 2019 · Past); Nextgen Healthcare Inc (Director · Sep 6, 2006 – Sep 6, 2006 · Past) | Director · Mar 22, 2012 – Mar 22, 2012 · Past |
| Geoffrey E Harris Other companies: Vyant Bio Inc (Director · Mar 30, 2021 – Jan 17, 2023 · Past); Cancer Genetics Inc (Director · Sep 28, 2017 – Jul 23, 2019 · Past) | Director · Dec 5, 2017 – Oct 8, 2018 · Past |
| John Pappajohn Other companies: American Caresource Holdings Inc (Director · Aug 28, 2015 – Jun 30, 2016 · Past); Cancer Genetics Inc (Director · Aug 26, 2015 – Jan 31, 2019 · Past) | Director · Aug 20, 2015 – May 23, 2019 · Past |
| Richard W Turner Other companies: Conmed Healthcare Management Inc (Chairman & CEO, Director · Dec 13, 2011 – Aug 28, 2012 · Past); American Caresource Holdings Inc (Chief Executive Officer, Director · Jun 30, 2011 – Jul 30, 2014 · Past) | Director · Feb 25, 2013 – May 23, 2013 · Past |
| Jane Pine Wood Other companies: Aspira Women's Health Inc. (Board Member · Since at least Jul 11, 2025) | Director · Mar 25, 2020 – Mar 25, 2020 · Past |
| Jon Kuwahara Other companies: Eledon Pharmaceuticals, Inc. (See Remarks · May 20, 2019 – Sep 11, 2020 · Past) | Director · Oct 1, 2024 – Oct 1, 2024 · Past |
| Michal Votruba Other companies: BioXcel Therapeutics, Inc. (Director · Since at least Mar 7, 2019) | Director · Jul 30, 2015 – Oct 8, 2018 · Past |
All 29 people
| Person | Seat |
|---|---|
| Peter Ludlum Other companies: Pulmatrix, Inc. (Interim Chief Executive Officer · Since at least Apr 18, 2022) | Chief Business Officer · May 10, 2016 – May 10, 2016 · Past |
| Alfred Fu Kong Lui | Director · Nov 23, 2021 – Jan 3, 2022 · Past |
| Charles W. Stark | Senior Vice President of Medical Affairs, Clinical, Regulatory · Since at least Nov 23, 2021 |
| Dale E. Short | Legal Consultant and Corporate Secretary · Since at least Nov 5, 2026 |
| George C Carpenter IV | Chief Innovation Officer · Oct 1, 2007 – Dec 12, 2018 · Past |
| George Sekulich | Co-President & CCO, Director · Nov 23, 2021 – Feb 1, 2024 · Past |
| Henry Du | Director · Since at least Nov 5, 2026 |
| Hiroko Huynh | Chief Accounting Officer · Since at least Nov 4, 2026 |
| Ian Harvey Zwicker | Director · Jul 17, 2019 – Feb 1, 2024 · Past |
| Joseph Charles Sherwood III | Chief Financial Officer · Jul 17, 2019 – Jul 17, 2019 · Past |
| Lan T Tran | Chief Administrative Officer · Jul 17, 2019 – Jul 17, 2019 · Past |
| Lori Teranishi | Director · Jan 6, 2022 – Jan 6, 2022 · Past |
| Masaharu Osato | Director · May 10, 2016 – Jul 17, 2019 · Past |
| Paul Buck | Chief Financial Officer · Feb 15, 2011 – Nov 1, 2016 · Past |
| Peter Unanue | Director · Sep 19, 2017 – Oct 8, 2018 · Past |
| Seah H Lim | Director · Oct 4, 2022 – Sep 16, 2024 · Past |
| Wei Peu Zen | Director · Since at least Nov 5, 2026 |
| Willis C. Lee | CEO, Director · Since at least Apr 4, 2022 |
| Yasushi Nagasaki | CFO · Jan 12, 2023 – Feb 1, 2024 · Past |
Log in to ask 6ix AI your own questions about Emmaus Life Sciences, Inc.